Pomerantz Pursues Securities Action Against Varonis Following Earnings Miss

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Pomerantz Law Firm files class action lawsuit against Varonis Systems for securities fraud following a 63.9% revenue decline and 48.67% stock drop.

Pomerantz Pursues Securities Action Against Varonis Following Earnings Miss

Pomerantz Law Firm has initiated a class action lawsuit against Varonis Systems, Inc., alleging securities fraud and unlawful business practices stemming from the company's October 28, 2025 earnings announcement. The disclosure revealed a significant 63.9% decline in term license subscription revenues, prompting management to reduce full-year annual recurring revenue (ARR) guidance due to underperformance in the on-premises subscription segment. The market reaction was severe, with Varonis shares declining 48.67% in the days following the announcement.

The lawsuit represents efforts by investors who sustained losses during this period to pursue claims against the company and its leadership. The material revenue shortfall and subsequent guidance reduction raise questions about the accuracy of prior financial projections and management's disclosure practices regarding business performance trends. Investors who purchased or held Varonis securities during the relevant period and experienced losses are being notified of the litigation opportunity.

Investors seeking to participate in the class action as Lead Plaintiff must meet the March 9, 2026 deadline. Participation in the lawsuit allows shareholders to potentially recover losses without bearing individual litigation costs, as the case proceeds on a class-wide basis against the company.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 24

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON